Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study

Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study

Abstract Background Staphylococcal species account for more than 50% of periprosthetic joint infections (PJI) and antimicrobial therapy with rifampin-based combination regimens has been shown effective. The present study evaluates the safety and efficacy of clindamycin in combination with rifampin f...

Full description

Bibliographic Details
Main Authors: Borg Leijtens, Joris B. W. Elbers, Patrick D. Sturm, Bart Jan Kullberg, Berend W. Schreurs
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Infectious Diseases
Subjects:
Clindamycin
Rifampin
Periprosthetic joint infection
Staphylococcus
Online Access:http://link.springer.com/article/10.1186/s12879-017-2429-2

Internet

http://link.springer.com/article/10.1186/s12879-017-2429-2

Similar Items